These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

366 related articles for article (PubMed ID: 12474294)

  • 41. A clinical picture of child and adolescent narcolepsy.
    Dahl RE; Holttum J; Trubnick L
    J Am Acad Child Adolesc Psychiatry; 1994; 33(6):834-41. PubMed ID: 8083140
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [NARCOLEPSY WITH CATAPLEXY: TYPE 1 NARCOLEPSY].
    Dauvilliers Y; Lopez R
    Rev Prat; 2016 Jun; 66(6):671-6. PubMed ID: 27538328
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The neurobiology of hypocretins (orexins), narcolepsy and related therapeutic interventions.
    Zeitzer JM; Nishino S; Mignot E
    Trends Pharmacol Sci; 2006 Jul; 27(7):368-74. PubMed ID: 16766052
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [A six year-old case of narcolepsy].
    Fujii Y; Fukumizu M; Sugai K; Kanbayashi T; Oyama K; Kamei A
    No To Hattatsu; 2003 Nov; 35(6):505-10. PubMed ID: 14631747
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Diagnosis and treatment of epilepsy and narcolepsy comorbid].
    Yang ZX; Han F; Qin J; Liu XY
    Zhonghua Er Ke Za Zhi; 2013 Sep; 51(9):676-8. PubMed ID: 24330987
    [TBL] [Abstract][Full Text] [Related]  

  • 46. REM behavior disorder (RBD) can be one of the first symptoms of childhood narcolepsy.
    Nevsimalova S; Prihodova I; Kemlink D; Lin L; Mignot E
    Sleep Med; 2007 Nov; 8(7-8):784-6. PubMed ID: 17569582
    [TBL] [Abstract][Full Text] [Related]  

  • 47. HLA-DQB1 genotyping in a family with narcolepsy-cataplexy.
    Pedrazzoli M; Pontes JC; Peirano P; Tufik S
    Brain Res; 2007 Aug; 1165():1-4. PubMed ID: 17658488
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [HLA-DRB and -DQB allele contribution to narcolepsy susceptibility in Chinese patients with narcolepsy].
    Han F; Chen EZ; Wei HL; Dong XS; Li J; Li M; He QY; Ding DJ
    Zhonghua Yi Xue Za Zhi; 2003 Apr; 83(8):644-6. PubMed ID: 12887819
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Diagnostic difficulties in the narcolepsy-catalepsy syndrome: with reference to our series of cases].
    Benetó A; Rubio P; Gómez E; Puertas FJ; Domínguez F; Valdivieso R; Entrambasaguas M
    Rev Neurol; 1997 Feb; 25(138):208-11. PubMed ID: 9147737
    [TBL] [Abstract][Full Text] [Related]  

  • 50. CSF hypocretin-1 levels and clinical profiles in narcolepsy and idiopathic CNS hypersomnia in Norway.
    Heier MS; Evsiukova T; Vilming S; Gjerstad MD; Schrader H; Gautvik K
    Sleep; 2007 Aug; 30(8):969-73. PubMed ID: 17702265
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The neurobiology, diagnosis, and treatment of narcolepsy.
    Scammell TE
    Ann Neurol; 2003 Feb; 53(2):154-66. PubMed ID: 12557281
    [TBL] [Abstract][Full Text] [Related]  

  • 52. CSF hypocretin measures in patients with obstructive sleep apnea.
    Kanbayashi T; Inoue Y; Kawanishi K; Takasaki H; Aizawa R; Takahashi K; Ogawa Y; Abe M; Hishikawa Y; Shimizu T
    J Sleep Res; 2003 Dec; 12(4):339-41. PubMed ID: 14633246
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Hypersomnolence and increased REM sleep with low cerebrospinal fluid hypocretin level in a patient after removal of craniopharyngioma.
    Tachibana N; Taniike M; Okinaga T; Ripley B; Mignot E; Nishino S
    Sleep Med; 2005 Nov; 6(6):567-9. PubMed ID: 16084764
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Narcolepsy. Diagnosis and treatment.
    Dement WC; Carskadon MA; Guilleminault C; Zarcone VP
    Prim Care; 1976 Dec; 3(4):609-23. PubMed ID: 1051517
    [TBL] [Abstract][Full Text] [Related]  

  • 55. CSF hypocretin-1 (orexin-A) concentrations in narcolepsy with and without cataplexy and idiopathic hypersomnia.
    Kanbayashi T; Inoue Y; Chiba S; Aizawa R; Saito Y; Tsukamoto H; Fujii Y; Nishino S; Shimizu T
    J Sleep Res; 2002 Mar; 11(1):91-3. PubMed ID: 11869432
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Correlates of sleep-onset REM periods during the Multiple Sleep Latency Test in community adults.
    Mignot E; Lin L; Finn L; Lopes C; Pluff K; Sundstrom ML; Young T
    Brain; 2006 Jun; 129(Pt 6):1609-23. PubMed ID: 16597649
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Cerebrospinal fluid hypocretin-1 levels in multiple system atrophy.
    Martinez-Rodriguez JE; Seppi K; Cardozo A; Iranzo A; Stampfer-Kountchev M; Wenning G; Tolosa E; Högl B; Santamaria J; Poewe W;
    Mov Disord; 2007 Sep; 22(12):1822-4. PubMed ID: 17659646
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Narcolepsy and other non-SAS hypersomnia in sleep breathing disorders clinic.
    Banno K; Shiomi T; Sasanabe R; Hasegawa R; Otake K; Yamakawa H; Kobayashi T; Horiba K; Nishino S
    Psychiatry Clin Neurosci; 2001 Jun; 55(3):203-4. PubMed ID: 11422842
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Current aspects in the diagnosis and therapy of narcolepsy].
    Mathis J
    Schweiz Med Wochenschr; 1992 Sep; 122(38):1385-93. PubMed ID: 1411396
    [TBL] [Abstract][Full Text] [Related]  

  • 60. On the value of measuring CSF hypocretin-1 in diagnosing narcolepsy.
    Mignot E; Chen W; Black J
    Sleep; 2003 Sep; 26(6):646-9. PubMed ID: 14572113
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.